The Presidential Council for Economic Modernization and Innovative Development of Russia approved Project No. 30, ChemRar Center for development of innovative and import-substituting drugs.
ChemRar Center for development of innovative and import-substituting drugs.
Goal: To create a technological platform for the development of finished dosage forms and production of pilot batches of medicines.
Goal: To develop technologies for the production of generics, including finished dosage forms — 10 INN: 8 of them are in production, 1 is in the process of marketing authoriztion. A total of 27 INN are in the process of development: 11 are in production, 9 are Vital and Essential Drugs (VED).
Goal: To create a technological platform for innovative exportable drug development.
Goal: To develop innovative export-capable cadidate clinical drugs up to and including Phase 2 clinical trials — 10 candidate drugs in innovative medicines, including 8 in phase 2 & 3 clinical trials. A total of 12 innovative drugs for phase 2 & 3 clinical trials are in the process of development, one is in the process of marketing authorization.